Your browser doesn't support javascript.
loading
Interval Cancer in Population-Based Colorectal Screening Programmes: Incidence and Characteristics of Tumours.
Vanaclocha-Espí, Mercedes; Pinto-Carbó, Marina; Ibáñez, Josefa; Valverde-Roig, María José; Portillo, Isabel; Pérez-Riquelme, Francisco; de la Vega, Mariola; Castán-Cameo, Susana; Salas, Dolores; Molina-Barceló, Ana.
Afiliação
  • Vanaclocha-Espí M; Foundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO)-Public Health, 46020 Valencia, Spain.
  • Pinto-Carbó M; Foundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO)-Public Health, 46020 Valencia, Spain.
  • Ibáñez J; Foundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO)-Public Health, 46020 Valencia, Spain.
  • Valverde-Roig MJ; General Directorate of Public Health, Valencian Community, 46020 Valencia, Spain.
  • Portillo I; General Directorate of Public Health, Valencian Community, 46020 Valencia, Spain.
  • Pérez-Riquelme F; The Basque Health Service, 48011 Bilbao, Spain.
  • de la Vega M; General Directorate of Public Health, Murcia Region, 30008 Murcia, Spain.
  • Castán-Cameo S; General Directorate of Assistance Programmes, 38071 Santa Cruz de Tenerife, Spain.
  • Salas D; General Directorate of Public Health, Valencian Community, 46020 Valencia, Spain.
  • Molina-Barceló A; Foundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO)-Public Health, 46020 Valencia, Spain.
Cancers (Basel) ; 16(4)2024 Feb 13.
Article em En | MEDLINE | ID: mdl-38398160
ABSTRACT
The objective of this study is to evaluate interval cancer (IC) in colorectal cancer (CRC) screening, which is CRC diagnosed in an individual after having received a negative faecal occult blood test and before the next invitation to participate in screening. A follow-up study was conducted on a cohort of participants in the first three screening rounds of four colorectal cancer screening programmes in Spain, n = 664,993. A total of 321 ICs and 2120 screen-detected cancers (SCs) were found. The IC and SC rates were calculated for each guaiac (gFOBT) or immunochemical (FIT) test. A Cox regression model was used to estimate the hazard ratios (HR) of IC risk factors. A nested case-control study was carried out to compare IC and SC tumour characteristics. The IC rate was 1.16‱ with the gFOBT and 0.35‱ with the FIT. Men and people aged 60-69 showed an increased probability of IC (HR = 1.81 and HR = 1.95, respectively). There was a decreased probability of IC in individuals who regularly participated in screening, HR = 0.62 (0.47-0.82). IC risk gradually rose as the amount of Hb detected in the FIT increased. IC tumours were in more advanced stages and of a larger size than SC tumours, and they were mostly located in the cecum. These results may play a key role in future strategies for screening programmes, reducing IC incidence.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article